Alabama hemp bill creates confusion; industry braces for fight
A bill aimed at regulating consumable hemp products has landed on Gov. Kay Ivey's desk, but its future is uncertain.
HB 445, sponsored by Rep. Andy Whitt, R-Harvest, would establish regulations for consumable hemp products in Alabama, but the bill's language and potential consequences have led the hemp industry to suggest the possibility of litigation and led to uncertainty among lawmakers, business owners, patients and lobbyists.
'It is my hope that the governor signs the bill this week. I think it's a good piece of legislation. I think it's a bipartisan piece of legislation, and certainly, we have to get the guardrails up on this industry,' Whitt said in a phone interview Tuesday.
SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
Key provisions of the bill include:
Testing and labeling requirements for all consumable hemp products.
Caps of 10 milligrams per individually wrapped product, with a cap of 40 milligrams per package.
Authorization for the Alcoholic Beverage Control (ABC) Board to license retailers of these products.
Restrictions on retail establishments selling hemp products.
Prohibition of sales to minors.
Prohibition of smokable hemp products and restrictions on online sales and direct delivery.
Imposition of an excise tax on consumable hemp products.
The bill defines 'consumable hemp product' broadly as any finished product intended for human or animal consumption that contains any part of the hemp plant or its derivatives, but explicitly bans smokable hemp products and certain psychoactive cannabinoids.
It's unclear whether the bill would ban CBD, a non-psychoactive cannabinoid found in hemp. According to the bill, 'any smokeable hemp product' not limited to 'plant product or raw hemp material that is marketed to consumers as hemp cigarettes, hemp cigars, hemp joints, hemp buds, hemp flowers, hemp leaves, ground hemp flowers, or any variation of these terms to include any product that contains a cannabinoid, whether psychoactive or not.'
The bill was replaced with a substitute on the floor that had not been discussed in the Senate committee hearing, and a copy was not made available to the public until after its passage. Molly Cole, a lobbyist for the Alabama Hemp and Vape Association, said she wished a senator had asked for the bill to be read on the floor.
'When Sen. Melson came onto the floor and proposed this bill for the substitute, … no one called for it to be read on the floor. And then the way he proposed it was that all this bill does is move products to 21 and up stores,' Cole said, which she felt was misleading.
Even the bill's sponsor and the senator who handled the bill in the upper chamber appear to be at odds over its implementation.
Sen. Tim Melson, R-Florence, whose bill aimed at hemp regulation failed in committee but who handled Whitt's legislation in the Senate, said in an interview Tuesday that he was uncertain about whether the bill bans hemp-derived THC vapes. He thought that hemp-derived vapes could still be purchased in a 21+ vape shop.
'The hemp vape products, yes, anything with the THC would go to, my understanding … they would go to vape stores. But that being said, I'd have to double check now that you got me questioning,' Melson said.
Whitt, however, was clear on the matter.
'Any smokeable, any inhalable product, is banned under this legislation. Vapes would be banned as well that had delta-8 and (delta)-9 in those,' he said.
Delta-8 THC and delta-9 THC are psychoactive compounds found in cannabis, according to the U.S. Food and Drug Administration (FDA).
Representatives of the hemp industry strongly oppose the measure, warning of consequences for both businesses and consumers.
Carmelo Parasiliti, founder and CEO of Green Acres Organic Pharms in Florence, pointed to the potential damage the bill could have on his business. Parasiliti said that nearly every product they currently offer is federally legal and lab tested. Under HB 445, he said, it would all be illegal.
'We're going to keep our storefront open and serve Alabama to the best of our ability, but our future in Alabama is uncertain, and I'm really hoping Gov. Kay Ivey will veto this bill if she truly supports small businesses,' Parasiliti said in an interview Tuesday.
He also pointed to potential harm to people who benefit from hemp medically, particularly those in a cancer program he started to provide free or low-cost hemp-derived products to people referred by providers.
'Even more troubling is the bill makes it unlawful to give these products away to people in need, no matter their condition, which I think is cruelty,' Parasiliti said.
Nancy Owen Nelson, a cancer patient living in Florence who uses hemp, mostly CBD, for symptom management and a participant in the Green Acres Organic Pharm cancer program, said she was disappointed with the bill. Nelson said he plans to write a letter to Ivey encouraging her to veto it. She said she tried to leave a voicemail, but found it was full.
'The thing about this condition is that it is not anywhere in particular, so it is a whole body sensation, and a whole body fatigue. It helps me sleep, it helps me rest, and it helps me feel calmer,' Owen Nelson said.
Whitt and Melson say that the bill's primary objective is to protect children and regulate an industry that has operated largely unchecked. Owen Nelson said she agrees with regulating the hemp industry but feels the bill goes too far, and that she wasn't sure if the bill would accomplish its intent of limiting access for minors, saying that children will find a way to these products.
'It's the responsibility of the vendors to not sell children and the families to protect their children within their homes,' she said.
Whitt felt strongly that the need for 'guardrails' on the hemp industry, saying it was his goal to rein in 'the wild west of what's been derived out of the 2018 Farm Bill.'
The 2018 Farm Bill removed hemp and any cannabis product with no more than 0.3% THC by dry weight from the definition of marijuana under federal law.
Molly Cole, a lobbyist for the Alabama Hemp and Vape Association, said the industry is confused about how the bill defines consumable hemp product. She also pointed to conflicting implementation dates, which say that the 'act shall become effective on July 1, 2025,' but indicate that businesses have until Jan. 1, 2026, to comply.
'That's causing a lot of chaos and confusion,' she said.
The hemp industry is urging Ivey to veto HB 445. Gina Maiola, a spokeswoman for the governor, did not respond to a request for comment. If the governor vetoes the bill, the Legislature could override her veto, but it's also unclear whether the Legislature has the votes. The bill passed with a 60-27 vote and 14 abstentions out of the House and a 19-13 vote in the Senate.
Parasiliti said he is hopeful for a veto.
'The governor's office just celebrated last week small business week, and here we are,' he said. 'If this bill is signed and put into law, it's going to be putting a lot of small businesses out of business.'
Cole said that litigation is being considered, saying that 'the entire industry is looking at best practices moving forward, and litigation is being contemplated.'
'We're just trying to figure out what exactly is going to happen and what is not going to happen before we really start doing anything, but we are discussing it,' she said.
The Alabama Policy Institute, a conservative think tank, also came out against the bill, though for different reasons, claiming on X, formerly known as Twitter, that the bill would legalize recreational cannabis use 'under the guise of protecting children.'
Adding to the opposition, Birmingham Mayor Randall Woodfin posted a statement on Facebook saying the bill undermines progress made in cannabis reform and harms small businesses.
'Alabama House Bill 445 is a step backwards and harmful to small businesses in Birmingham,' Woodfin said. 'Instead of moving us closer to justice and equity, this bill risks dragging us back to an era of cannabis criminalization, overregulation, and lost opportunity.'
SUPPORT: YOU MAKE OUR WORK POSSIBLE

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 hours ago
- Yahoo
Bad weather, disease and trade troubles hit Michigan cherry farmers
STORY: Don Gallagher is driving through his cherry tree orchard in Michigan. Most of these trees have been harvested, but Don and his family are out one bright day to pick what's still on the branches so they can stock a farm stand. The fruit sold quickly. Here's his daughter. "This morning we put out 24 quarts, and we're down to six quarts." It's a bit of bright news in otherwise hard times. A cold snap in late April bit hard. 'Oh it got so extremely cold... we lost three quarters of our dark sweets, half of our briners, and all of our sour cherries, tart cherries.' Trump-era cuts have hit rural services, from farmworker visa processing to agricultural research. One family farm here hires part of their farm labor crew from Guatemala. The crew arrived short-handed and weeks into harvest, because the process of securing their federally-approved H-2A agricultural worker visas in Guatemala City was delayed. Producers say a U.S. Postal Service reorganization is moving fresh fruit boxes slower to some customers. So farmers are paying more to send them through private carriers. Related Videos Trump-Putin Meeting: WSJ Reporter Breaks Down Alaska Summit on Ukraine Trump, Putin Call Talks 'Productive,' a 'Starting Point' Trump and Putin Fail to Reach Deal on Ukraine During Alaska Summit Trump, Putin Summit in Alaska: Full Statements A local grower's federal grant for building a new chiller is in limbo, and scientists are not sure if they'll receive grant reimbursement for research into cherry diseases that growers rely - given Washington's funding cuts to universities and USDA programs. It's all squeezing the $227 million U.S. tart cherry industry hard. 'It's just hard to be a farmer. And that's it.' Between bad weather, plant disease, and pests, the U.S. Department of Agriculture has forecast that Michigan will lose 41% of its tart cherry crop this year, compared to last season. USDA expects northwest Michigan to show the state's sharpest year-over-year decline, in the state's smallest crop since 2021. Emily Miezio owns Cherry Bay Orchards. 'I'm going to say that we're about 40 percent of what we had last year. There are growers in this area that are not harvesting anything on their farms.' Traverse City, Michigan, calls itself the "Cherry Capital of the World." On the city's northern edge is the Northwest Michigan Horticulture Research Center, a 137-acre test farm. "We do horticulture research, entomological research and plant pathology..." Run by Michigan State University and funded by USDA grants and grower money, it's where Dr. Nikki Rothwell has spent more than two decades helping orchards thrive. "I would say that our little research station is probably... You know, I don't want to say it's a lifeline, but it is a lifeline for a lot of our growers to figure out kind of how to manage their crops on a daily basis." When researchers here fired up the tree shaker, a rust-colored cloud fell with the fruit and leaves: brown rot spores, thick as flour dust. Rothwell's research into the disease is meant to help growers around here keep their fruit trees from failing. She's unsure if the Trump administration will continue to fund it. This month, she's submitting final paperwork for a $100,000 USDA grant awarded under the Biden administration for a climate-related disease study. It's money that's now under a federal review of climate-related research. She said colleagues at other land-grant schools haven't been paid. Worries over an immigration crackdown have hurt the harvest, too. One grower in Oregon told Reuters he could only hire 47 farm workers at the beginning of harvest in June, when he needed 120. He blamed ICE raids in California for scaring away workers. He said he watched half a million pounds of cherries rot on the trees because he couldn't get enough farm labor. White House spokeswoman Abigail Jackson told Reuters President Donald Trump is committed to ensuring farmers have the workforce they need, but said there will be no safe harbor for 'criminal illegal immigrants.' She noted the Labor Department last month created a temporary Office of Immigration Policy to help employers navigate foreign labor certification programs. And then, there's the shrinking exports. U.S. Census Bureau trade data shows that last year, the U.S. exported nearly $506 million in fresh cherries. In the first half of this year, as President Donald Trump's trade wars reignited, U.S. fresh fruit exports fell 17% in volume and 15% in value. 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤


Los Angeles Times
9 hours ago
- Los Angeles Times
Trump's D.C. takeover is a desperate distraction from Epstein files
Atty. Gen. Pam Bondi's decision to appoint an 'emergency police commissioner' in Washington is just the latest attempt to change an increasingly uncomfortable subject for the White House. Last month President Trump told the American people he was never briefed on the files regarding Jeffrey Epstein, who in 2019 was charged with sex trafficking minors. We now know that Bondi told the president in May that his name appeared multiple times in those files, which traced Epstein's operation back to the mid-1990s. So — either you believe a city experiencing a 30-year low in crime is suddenly in need of an emergency police commissioner or you agree with Joe Rogan's assessment: This administration is gaslighting the public regarding those files. Now there will be pundits who will try to say Republicans are too focused on kitchen table issues to care about the Epstein controversy. If only that were true. According to the Consumer Price Index, goods cost more today than they did a month ago. And prices are higher than they were a year ago. It would be wonderful if Congress were in session to address kitchen table issues like grocery prices. However, Speaker Mike Johnson (R-La.) ended the House session early to avoid a vote on the release of the Epstein files — a vote that could have displeased Trump. Those are the lengths some in the MAGA movement are willing to go to prevent the public from knowing the truth about Epstein's clients. That is the backdrop for what is currently happening in the streets of Washington. It's not inspired by a rise in crime, but by a fear of transparency. It's important to look at Bondi's 'emergency police commissioner' decision with clear, discerning eyes because the administration is purposefully conflating the issues of crime and homelessness in order to win back support from Trump's base. While it is true that the district has made huge progress against crime, and the number of unhoused residents is far lower than a decade ago even though homeless populations nationwide have soared, the rise of conspicuous encampments around Washington is one of the reasons Virginia was almost able to lure away the city's NBA and NHL teams. However, the nation's capital was able to keep those sports franchises because of the leadership of Mayor Muriel Bowser. Instead of taking over the city's police force, perhaps Bondi should ask Bowser for some advice that could be replicated in other cities nationwide. Ask the mayor's office what resources it might need to continue its progress on homelessness and crime. But again, this really isn't about what benefits the people, is it? It's really about what's in the best interest of one person. Now there will be pundits who will try to tell you Republicans are too focused on making this country 'great' to worry about who is in the Epstein files. I ask you, when has trampling over democracy ever made us great? In Iran, we contributed to the overthrowing of Mohammad Mosaddegh in the 1950s, and we continue to be at odds with the nation. In Chile in the early 1970s, we moved against Salvador Allende, and it took 20 years to normalize our relationship again. Here at home, in 2010, the state of Michigan took over the predominantly Black city of Benton Harbor under the guise of a financial emergency. The City Council was prevented from governing as state officials tried to save the city from a crippling pension deficit and other financial shortages. There was temporary reprieve, but Benton Harbor is still on economic life support. That's because the issue wasn't the policies of the local government. It was the lasting effects of losing so much tax revenue to a neighboring suburb due to white flight. The explanation for Benton Harbor's woes lies in the past, not the present. The same is true in Washington. The relatively young suburbs of McLean and Great Falls, Va., are two of the richest in the country. When you have the same financial obligations of yesteryear but less tax revenue to operate with, there will be shortfalls. And those gaps manifest themselves in many ways — rundown homes, empty storefronts, a lack of school resources. Those are legitimate plagues affecting every major city. What Bondi is doing in Washington isn't a cure for what ails it. And when you consider why she's doing what she's doing, you are reminded why people are so sick of politics. YouTube: @LZGrandersonShow
Yahoo
18 hours ago
- Yahoo
Merck KGaA ventures into new territory in the US
This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Merck KGaA has been making new moves to propel itself into becoming what CEO Belén Garijo described as a 'globally diversified science and technology powerhouse.' Most recently, the company closed its $3.4 billion acquisition of Pfizer spinout SpringWorks Therapeutics, which will help it stake a claim in the rare tumor space. And in general, it's all about 'doubling down' on R&D and building the company's U.S. footprint, said Miguel Fernández Alcalde, president of EMD Serono, Merck KGaA's healthcare business in the U.S. and Canada. Germany-based Merck KGaA has undergone a number of transformations throughout its deep history. In 2022, the company restructured into three distinct business units including one focused on the life sciences sector and manufacturing services. But with the contract manufacturing blitz of the COVID-19 pandemic era fading, the company is refocusing. EMD Serono relocated its U.S. headquarters to Boston's Seaport district to place itself squarely in the thick of the region's most innovative 'biotechs, startups, academia and scientists,' Fernández Alcalde said. 'I want to make sure we are bringing the U.S. [business] to the next level in terms of contributions to the whole organization." Miguel Fernández Alcalde President, EMD Serono Merck KGaA also elevated its global head of R&D and chief medical officer of its healthcare business, Dr. Danny Bar-Zohar, to healthcare CEO. 'That tells you that the company's moving along in the direction of doubling down on R&D,' Fernández Alcalde said. Fernández Alcalde's appointment to president of EMD Serono in December is also part of the company's overall quest to build its U.S. footprint and bolster R&D through external deals. 'I want to make sure we are bringing the U.S. [business] to the next level in terms of contributions to the whole organization,' he said. 'I do think we have lots of opportunities in the U.S. ecosystem and U.S. market. My job and my vision and ambition is to really untap all those things that we have ahead of us.' A pharmacist by trade, Fernández Alcalde has been with Merck KGaA since 2014, serving most recently as EMD Serono's chief operating officer. 'That gave me a lot of knowledge and understanding of the business of the company in the States and the teams, the dynamics, the culture, but also the U.S. [healthcare] ecosystem,' he said. Driving dealmaking Central to Fernández Alcalde's role is supplementing the company's current pipeline through external innovation investments, including more strategic in-licensing and co-development opportunities. The SpringWorks acquisition put the company on track to generate at least 50% of its future launch assets from external companies, compared to roughly 10%-15% just 18 months ago. 'It's easily a fivefold increase in our ambition from external innovation,' Fernández Alcalde said. In terms of what kinds of deals they're targeting, Fernández Alcalde said several factors are at play. 'We are not looking [for] the $40 billion type of acquisition,' he said. Nor will they chase first-in-class potential blockbusters with never-explored mechanisms of action. Instead, they'll target smaller deals with the 'right risk balance' for their pipeline. He pointed to the SpringWorks acquisition as an example, which not only adds two FDA-approved drugs to its portfolio, but also a 'runway of three to five years of nice growth' in the form of several clinical-phase pipeline candidates. 'These areas where we have deep, good science [and a] validated proof of concept or an about-to-be-validated proof of concept where the mechanism of action is already validated, is something we are interested in,' he said. The company will take a similar approach when it comes to therapeutic areas by branching out within reason. 'We are not sticking to the [therapeutic areas] we have today, but we are not going to go wild, either,' he said. Rather, they'll look for specialties that are 'adjacent' and 'logical' in terms of what they've been historically known for, such as oncology and neurology/immunology. Again, he pointed to the SpringWorks acquisition as an example and noted that some might ask what track record EMD Serono or Merck KGaA has in rare tumors. 'The answer is zero. But we do know how to commercialize,' he said. Plus, 'it's in an adjacent area of oncology.' Fernández Alcalde is also thinking globally, intending to follow good science wherever it leads and consider deals from around the world. 'We couldn't care less about where that science is coming from, whether it's China, my home country Spain, the U.S. or South Africa,' he said. 'If we think that science will help patients … we will definitely think about it.' Recommended Reading Let's make a deal? Big Pharma execs express varying views on their M&A future